Deutsche Bank Reiterates Sell Rating on ALS
Deutsche Bank has maintained its bearish stance on ALS, despite recent fluctuations in the stock's price. The firm reconfirmed its sell rating and lowered its price objective on shares of Rexam PLC, while reaffirming its buy rating on Smith & Nephew plc and hold rating on CRH PLC. In a separate development, Citigroup Inc. analysts also reiterated a sell rating on ALS, setting a price target of $5.00. ALS has experienced a significant price swing in the past year, trading between A$4.330 and A$9.300.
Key Takeaways:
- Deutsche Bank reiterates sell rating on ALS, with a current price objective of $4.44.
- The firm has also downgraded its price target on Rexam PLC from GBX 500 to GBX 485, while maintaining a hold rating.
- Deutsche Bank reaffirms its buy rating on Smith & Nephew plc and hold rating on CRH PLC.
- Citigroup Inc. analysts have also reiterated a sell rating on ALS, setting a price target of $5.00.
- ALS has a one year low of A$4.330 and a one year high of A$9.300, with a 50-day moving average of A$5.0 and a 200-day moving average of A$6.16.
- The company has a market cap of A$1.935 billion and a price-to-earnings ratio of 16.96.
- ALS Limited provides technical testing and inspection services, distribution of cleaning agents, and other industrial operations.
Statistics:
- ALS opened at A$4.870 on Wednesday.
- ALS has a price objective of $4.44 from Deutsche Bank.
- Rexam PLC's price target has been lowered from GBX 500 to GBX 485.
- Citigroup Inc.'s price target for ALS is $5.00.
- ALS trading range: A$4.330 - A$9.300.
- 50-day moving average: A$5.0.
- 200-day moving average: A$6.16.
- Market cap: A$1.935 billion.
- Price-to-earnings ratio: 16.96.
Sources:
- Deutsche Bank report, November 2022.
- Deutsche Bank report on Rexam PLC, November 2022.
- Deutsche Bank report on Smith & Nephew plc, November 2022.
- Deutsche Bank report on CRH PLC, November 2022.
- Citigroup Inc. research note, November 28, 2022.